Synthon hierarchy in theobromine cocrystals with hydroxybenzoic acids as coformers

被引:13
作者
Goldyn, Mateusz [1 ]
Larowska, Daria [1 ]
Nowak, Weronika [1 ]
Bartoszak-Adamska, Elzbieta [1 ]
机构
[1] Adam Mickiewicz Univ, Fac Chem, Uniwersytetu Poznanskiego 8, PL-61614 Poznan, Poland
来源
CRYSTENGCOMM | 2019年 / 21卷 / 48期
关键词
CO-CRYSTALS; PHARMACEUTICAL COCRYSTALS; POLYMORPHS; CAFFEINE; DRUG; DESIGN; SALTS; CARBAMAZEPINE; DISSOCIATION; PYRAZINAMIDE;
D O I
10.1039/c9ce01195a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pharmaceutical cocrystals, multicomponent solids composed of molecular and/or ionic compounds connected by noncovalent interactions, are objects of interest in crystal engineering. Theobromine, as an active pharmaceutical ingredient, was used for cocrystallization with dihydroxybenzoic acids as crystal coformers. All of these dimethylxanthine derivatives were obtained by slow evaporation from solution and they were structurally-characterized by a single X-ray diffraction method. Solid-state synthesis products through grinding (green chemistry experiments) were confirmed by powder X-ray diffraction measurements. Simultaneous thermal analyses for samples from grinding were performed. The various supramolecular synthons formed by theobromine responsible for the arrangement of molecules in the crystal lattice of its cocrystals were specified. The hydrogen-bonded motifs present in these cocrystals together with theobromine-acid solids deposited in the CSD were summarized. Furthermore, UV-vis spectra measurements were made to check the change in the solubility of theobromine after its cocrystallization.
引用
收藏
页码:7373 / 7388
页数:16
相关论文
共 80 条
  • [1] Aakeröy CB, 2001, ANGEW CHEM INT EDIT, V40, P3240, DOI 10.1002/1521-3773(20010903)40:17<3240::AID-ANIE3240>3.0.CO
  • [2] 2-X
  • [3] Co-crystals of caffeine and piracetam with 4-hydroxybenzoic acid: Unravelling the hidden hydrates of 1: 1 co-crystals
    Aitipamula, Srinivasulu
    Chow, Pui Shan
    Tan, Reginald B. H.
    [J]. CRYSTENGCOMM, 2012, 14 (07): : 2381 - 2385
  • [4] [Anonymous], 2014, CrysAlis PRO
  • [5] [Anonymous], INDO AM J PHARM RES
  • [6] [Anonymous], 2007, TENOFOVIR DISOPROXIL
  • [7] [Anonymous], 2006, CRYSALIS RED
  • [8] Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
    Babu, N. Jagadeesh
    Nangia, Ashwini
    [J]. CRYSTAL GROWTH & DESIGN, 2011, 11 (07) : 2662 - 2679
  • [9] Ritonavir: An extraordinary example of conformational polymorphism
    Bauer, J
    Spanton, S
    Henry, R
    Quick, J
    Dziki, W
    Porter, W
    Morris, J
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (06) : 859 - 866
  • [10] The prediction, morphology, and mechanical properties of the polymorphs of paracetamol
    Beyer, T
    Day, GM
    Price, SL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (21) : 5086 - 5094